Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Streamline Ayush systems of medicine: Parliamentary Panel

      Streamline Ayush systems of medicine: Parliamentary Panel

      Ruby Khatun Khatun2 April 2018 11:24 AM IST
      New Delhi: The need of the hour to streamline the Ayush systems of medicines by standardization and quality control of Ayurveda, Siddha, Unani and...
      HC restrains Andhra based pharmacy from using trademark of Apollo hospitals

      HC restrains Andhra based pharmacy from using trademark of Apollo hospitals

      Ruby Khatun Khatun2 April 2018 11:00 AM IST
      Chennai: The Madras High Court has directed an Andhra Pradesh-based pharmacy to desist from using the trademark words 'Apollo' in any manner.While...
      Policybazaar.com to foray into healthcare and tech services

      Policybazaar.com to foray into healthcare and tech services

      Ruby Khatun Khatun2 April 2018 10:00 AM IST
      New Delhi: Policybazaar.com, India's largest insurance website and comparison portal is planning to foray into the healthcare technology and services...
      Drug companies want Supreme Court to take eye drop dispute

      Drug companies want Supreme Court to take eye drop dispute

      Ruby Khatun Khatun2 April 2018 9:45 AM IST
      WASHINGTON: The Supreme Court is being asked to take a case about whether eye drops are too big.Don't roll your eyes. Major players in American's...
      Shire soars as Japans Takeda considers bid

      Shire soars as Japan's Takeda considers bid

      Ruby Khatun Khatun2 April 2018 9:30 AM IST
      LONDON/TOKYO: Japan's largest drugmaker Takeda Pharmaceutical is considering a bid for London-listed rare disease specialist Shire that could top $40...
      Lupin launches generic psoriasis drug in US

      Lupin launches generic psoriasis drug in US

      Ruby Khatun Khatun1 April 2018 10:30 AM IST
      New Delhi: Drug firm Lupin said it has launched its Clobetasol Propionate spray, used for treating plaque psoriasis, in the American market.The...
      Mylan gets FDA approval for HIV treatment

      Mylan gets FDA approval for HIV treatment

      Ruby Khatun Khatun1 April 2018 10:15 AM IST
      Global pharmaceutical company Mylan N.V. announced that it will introduce in the U.S. a third cost-saving HIV combination.The U.S. Food and Drug...
      Indian antibiotics usage witnessed 103 percent rise in 15 years: Study

      Indian antibiotics usage witnessed 103 percent rise in 15 years: Study

      Ruby Khatun Khatun1 April 2018 10:00 AM IST
      India witnessed the highest increase in antibiotic consumption among Low and Middle-Income Countries (LMICs) between 2000 and 2015, a study has...
      HealthCare Global Enterprises transfers entire stake holding in HCG Regency Oncology Healthcare

      HealthCare Global Enterprises transfers entire stake holding in HCG Regency Oncology Healthcare

      Ruby Khatun Khatun1 April 2018 9:45 AM IST
      New Delhi: HealthCare Global Enterprises Limited has informed the BSE that the company has entered into a Share Purchase Agreement with Regency...
      FDA expands use of Amgen leukemia drug Blincyto to patients with relapse risk

      FDA expands use of Amgen leukemia drug Blincyto to patients with relapse risk

      Ruby Khatun Khatun1 April 2018 9:30 AM IST
      The U.S. Food and Drug Administration (FDA) expanded the use of Amgen Inc’s leukemia drug Blincyto to include patients who are in remission but still...
      Lupin gets USFDA approval for generic psoriasis drug

      Lupin gets USFDA approval for generic psoriasis drug

      Ruby Khatun Khatun31 March 2018 10:30 AM IST
      New Delhi: Drug major Lupin said it has received USFDA's approval to market Clobetasol Propionate spray, used for treating plaque psoriasis, in the...
      Huge consignment of fake, prohibited medicines seized in Amroha, four held

      Huge consignment of fake, prohibited medicines seized in Amroha, four held

      Ruby Khatun Khatun31 March 2018 10:15 AM IST
      Amroha: Local police and drugs department in a joint operation seized huge consignment of fake and prohibited medicines in Hasanpur area.Assistant...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok